A simple, secure interface for the care team
Resilience's remote monitoring platform, a class IIa medical device, enables healthcare professionals to improve remote monitoring of their patients by giving them the possibility of :
- Measure treatment-related symptoms with tailored e-PRO questionnaires
- Follow their evolution and be alerted in real time according to the severity of reported side effects
- Quickly identify at-risk patients and adapt management to their needs
"The idea is that we can have a vision of the patient's care pathway, including outside the hospital walls, and anticipate problems as they arise."
"Telemonitoring has greatly improved the quality of care here (...) It's a win for patients and a win for us."
"It gives us continuous feedback and enables us to target our actions, and in particular those of our Advanced Practice Nurse, on certain patients in demand."
"Resilience is an easy tool to get to grips with and accepted very favorably by patients so it's a very interesting tool for monitoring my patients."
"It's a huge resource for our patients because they have a very personalized follow-up tailored to their needs. And on the other hand it's a huge resource for the professionals because we don't have the gap between the two consultations, between the two chemotherapy sessions."
"It's our job to take care of our patients, whether they're in clinic or at home. The only way to take care of them is to understand what they go through on a daily basis, and we need tools to help us do that."
"Resilience allows us to anticipate the scheduling of supportive care when patients come to the HDJ. Now everyone has the right to regular follow-up. There's no going back."
"You'll be able to devote medical and paramedical time simply to a need that emerges and when it emerges."
"With telemonitoring], we prevent major toxic effects. We improve the patient experience, [they] appreciate this close follow-up. And lastly [...], in economic terms, we reduce the number of hospitalization days. So it's very encouraging, because we're on the triptych of quality of care, patient experience and cost reduction. As far as we know, this is one of the first demonstrations for all cancers."
"I see telemonitoring as a tool that will enable us to be more efficient and to have this vision in the form of a continuum of care."
Facilitating care coordination and maintaining links with patients
99% of the time, a patient is not under the supervision of his or her oncologist. The link between patients and their care teams is eroding. Strengthening it has become a necessity to avoid, for example, non-compliance with treatment. Resilience enables patients to benefit from local support, even at a distance.
Some caregivers find that Resilience integrates satisfactorily into their organization*.
Nurses report that Resilience improves communication with their patients*.
Doctors report that Resilience can detect early deterioration or the onset of undesirable events.
*Satisfaction survey conducted by Resilience among caregivers using the solution - December 2022
e-PRO questionnaires tailored to your patients' needs
Conducted by oncologists and researchers, the construction of our adapted e-PRO (Patient Reported Outcome) questionnaires strictly follows ESMO guidelines. Applicable to all types of cancer, they are composed of a set of generic and specific questions to capture the impact of different tumor types and/or treatments, with a level of evidence and a grade of recommendation [I,A].
.webp)
.webp)
.webp)
1. Patient assesses symptoms
2. Nurses handle alerts
3. The oncologist intervenes if necessary
Scientifically proven clinical and organizational benefits
Remote medical monitoring in oncology has proven its impact on patient health and care organization through several French and international clinical trials.
Relative Dose Intensity (1)
Treatment-related toxicities (grade ≥3) (1)
of months of overall survival (2)
Day of hospitalization (1)
Emergency room use (1)
(1) Mir, O., Ferrua, M., Fourcade, A. et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anti-cancer agents: the randomized phase 3 CAPRI trial. Nat Med (2022). doi.org/10.1038/s41591-022-01788-1.
(2) Basch, Ethan et al. "Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A RandomizedControlled Trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34.6 (2016): 557-65. doi:10.1200/JCO.2015.63.0830
Safety and regulatory compliance as pillars
Our software has been designed to meet the most stringent international standards in terms of quality management, information system security and medical device design. We also place great emphasis on protecting our users' personal data and complying with European regulations.
- Medical device CE-marked (class IIa) under MDD 93/42
- Certified by GMED and registered with ANSM
- Compliant with European MDR 2017/745 (article 120)
- France's only Class IIa-certified platform
- Solutions developed with the protection of our users' data (healthcare professionals and patients) in mind
- Increased support from CNIL throughout 2021
- RGPD compliance
- Healthcare data hosted in France by approved healthcare data hosts (Ecritel, OVHcloud)
Meet our teams at upcoming events
Amina, Eugénie and Timothée, our Partnership Managers, will be happy to tell you more about Resilience and telemonitoring in oncology, and the impact of telemonitoring in oncology.
.webp)
Are you a healthcare professional and want to know more about Resilience? Contact us!
Understanding and monitoring to optimize medical intervention
Thanks to real-time data collection and an intelligent alert system, the care team can detect and predict relapses, toxicities or complications encountered by patients. Resilience also enables the care team to proactively adapt management and improve care pathway coordination.